Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).
For the
six
months ended in Dec. 2025, Ebos Groupspent$18 Mil on purchasing property, plant, equipment.
It gained$0 Mil from selling property, plant, and equipment.
It spent$57 Mil on purchasing business.
It gained$0 Mil from selling business.
It spent$-0 Mil on purchasing investments.
It gained$0 Mil from selling investments.
It paid$5Mil for net Intangibles purchase and sale.
And it paid$24 Mil for other investing activities.
In all, Ebos Groupspent$104 Mil on investment activities in financial market and operating subsidiaries for the
six
months ended in Dec. 2025.
Ebos Group's purchase of property, plant, equipment for the
six
months ended in Dec. 2025 was $-18 Mil. It means Ebos Group spent $18 Mil on purchasing property, plant, equipment.
In the capital spending for property, plant and equipment (PPE), some part of spending may be from the expansion of business. The business needs more property, plant and equipment (PPE) as it grows. Another part may be from replacement of the property, plant and equipment (PPE) of existing business. For some companies, the cash spent on replacing of the property, plant and equipment (PPE) of the existing business will be close to the depreciation of property, plant and equipment (PPE) reported in the income statement.
In Warren Buffett's definition of Owner's Earnings, he deducts the estimate of the cost of replacing the property, plant and equipment (PPE) of the existing business from cash flow from operations. The cash spent on the new property, plant, and equipment is not deducted. The reason is because these are not costs of the existing business. In his 1986 letter to shareholders, Warren Buffett wrote this about owner earnings:
"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume....Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."
Ebos Group's sale of property, plant, equipment for the
six
months ended in Dec. 2025 was $0 Mil. It means Ebos Group gained $0 Mil from selling property, plant, and equipment.
3.Purchase Of Business:
Purchase of business indicates the amount used to purchase business.
Ebos Group's purchase of business for the
six
months ended in Dec. 2025 was $-57 Mil. It means Ebos Group spent $57 Mil on purchasing business.
4. Sale Of Business:
Sale of business indicates the amount gained from selling business.
Ebos Group's sale of business for the
six
months ended in Dec. 2025 was $0 Mil. It means Ebos Group gained $0 Mil from selling business.
5. Purchase Of Investment:
Purchase of Investments represents cash outflow on the purchase of investments in securities.
Ebos Group's purchase of investment for the
six
months ended in Dec. 2025 was $0 Mil. It means Ebos Group spent {stock_data.stock.currency_symbol}}-0 Mil on purchasing investments.
6. Sale Of Investment:
Sale of Investments represents cash inflow on the sale of investments in securities.
Ebos Group's sale of investment for the
six
months ended in Dec. 2025 was $0 Mil. It means Ebos Group gained $0 Mil from selling investments.
7. Net Intangibles Purchase And Sale:
Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.
Ebos Group's net Intangibles purchase and sale for the
six
months ended in Dec. 2025 was $-5 Mil.
It means Ebos Group paid $5 Mil for net Intangibles purchase and sale.
8. Cash From Discontinued Investing Activities:
Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.
Ebos Group's cash from discontinued investing activities for the
six
months ended in Dec. 2025 was 0 Mil.
It means Ebos Group paid $0 Mil for discontinued investing activities.
9. Cash From Other Investing Activities:
Cash from other investing activities means the cash received by a company that comes from other investing activities.
Ebos Group's cash from other investing activities for the
six
months ended in Dec. 2025 was $-24 Mil.
It means Ebos Group paid $24 Mil for other investing activities.
Ebos Group Cash Flow from Investing Related Terms
Ebos Group Cash Flow from Investing Historical Data
* Premium members only.
The historical data trend for Ebos Group's Cash Flow from Investing can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).
If a company spends cash on property, plant and equipment (PPE), this will reduce their cash position. This is called Capital Expenditures (CPEX).
Likewise, if a company buys another company for cash, this will reduce their cash position.
Ebos Group's Cash Flow from Investing for the fiscal year that ended in Jun. 2025 is calculated as:
Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-254 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Flow from Investing of $-254 Mil mean?
Ebos Group (EBOSF) has a Cash Flow from Investing of $-254 Mil as of Dec. 2025. Cash Flow from Investing is the amount of cash earned or paid from investing operations. View historical data for Ebos Group and its competitors.
Is Ebos Group's Cash Flow from Investing too high?
Ebos Group's current Cash Flow from Investing is $-254 Mil. Overall, Ebos Group has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Ebos Group's Cash Flow from Investing compare to MCK and COR?
Ebos Group's Cash Flow from Investing of $-254 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Investing for a Medical Distribution company?
A good Cash Flow from Investing depends on the Medical Distribution industry context. However, Cash Flow from Investing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Investing mean?
A high Cash Flow from Investing can signal that a stock is expensive relative to its fundamentals. Cash Flow from Investing is the amount of cash earned or paid from investing operations. View historical data for Ebos Group and its competitors. Ebos Group's current Cash Flow from Investing is $-254 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ebos Group stock overvalued right now?
Ebos Group (EBOSF) has a current Cash Flow from Investing of $-254 Mil. The stock's GF Value™ is $43.75, compared to a current price of $23.75 — trading 45.7% below its estimated fair value. The current Cash Flow from Investing is $-254 Mil. Ebos Group's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Investing calculated?
Cash Flow from Investing is calculated from a company's financial statements. For Ebos Group (EBOSF), the current Cash Flow from Investing is $-254 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ebos Group (EBOSF) Overvalued in 2026?
Based on GuruFocus' analysis, Ebos Group stock appears to be undervalued.
The current stock price of $23.75 is trading 45.7% below its estimated GF Value™ of $43.75.
Key valuation signals for EBOSF:
Cash Flow from Investing: $-254 Mil
GF Value™: $43.75 vs. price of $23.75 (45.7% below fair value)
No single metric tells the full story. See the EBOSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ebos is the largest pharmaceutical wholesaler across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 50% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
80GF Score
Get the complete analysis for EBOSF
Cash Flow from Investing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EBOSF has been successfully added to your 
